Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension

Yang Mengliu, Yang Gangyi, Dong Jing, Liu Ying, Haihong Zong, Liu Hua, Guenther Boden, Li Ling

Research output: Contribution to journalArticle

Abstract

Chemerin is a recently discovered metabolic regulator hormone. The pathophysiologic role of this hormone in humans remains unknown. In this study, we have compared plasma chemerin levels in patients with type 2 diabetes mellitus with or without hypertension and in control subjects. We also assessed the association of plasma chemerin with body composition and metabolic parameters in these subjects. Plasma chemerin levels were found to be markedly increased in patients with type 2 diabetes mellitus with hypertension as compared with patients with type 2 diabetes mellitus and normal controls (P < 0.01). Multiple regression analysis showed that waist circumference, diastolic blood pressure, 2-hour plasma insulin after glucose overload, and HbA1c were independently related factors influencing plasma chemerin levels. The present work indicates the potential link of chemerin with the pathogenesis of insulin resistance, obesity, and metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)883-886
Number of pages4
JournalJournal of Investigative Medicine
Volume58
Issue number7
DOIs
StatePublished - Oct 2010

Fingerprint

Medical problems
Type 2 Diabetes Mellitus
Hypertension
Plasmas
Hormones
Insulin
Blood Pressure
Blood pressure
Waist Circumference
Body Composition
Regression analysis
Insulin Resistance
Obesity
Regression Analysis
Association reactions
Glucose
Chemical analysis

Keywords

  • Body composition
  • Chemerin
  • Hypertension
  • Metabolic parameters
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. / Mengliu, Yang; Gangyi, Yang; Jing, Dong; Ying, Liu; Zong, Haihong; Hua, Liu; Boden, Guenther; Ling, Li.

In: Journal of Investigative Medicine, Vol. 58, No. 7, 10.2010, p. 883-886.

Research output: Contribution to journalArticle

Mengliu, Yang ; Gangyi, Yang ; Jing, Dong ; Ying, Liu ; Zong, Haihong ; Hua, Liu ; Boden, Guenther ; Ling, Li. / Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. In: Journal of Investigative Medicine. 2010 ; Vol. 58, No. 7. pp. 883-886.
@article{33a647962f3849648a442551043a8cfe,
title = "Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension",
abstract = "Chemerin is a recently discovered metabolic regulator hormone. The pathophysiologic role of this hormone in humans remains unknown. In this study, we have compared plasma chemerin levels in patients with type 2 diabetes mellitus with or without hypertension and in control subjects. We also assessed the association of plasma chemerin with body composition and metabolic parameters in these subjects. Plasma chemerin levels were found to be markedly increased in patients with type 2 diabetes mellitus with hypertension as compared with patients with type 2 diabetes mellitus and normal controls (P < 0.01). Multiple regression analysis showed that waist circumference, diastolic blood pressure, 2-hour plasma insulin after glucose overload, and HbA1c were independently related factors influencing plasma chemerin levels. The present work indicates the potential link of chemerin with the pathogenesis of insulin resistance, obesity, and metabolic syndrome.",
keywords = "Body composition, Chemerin, Hypertension, Metabolic parameters, Type 2 diabetes mellitus",
author = "Yang Mengliu and Yang Gangyi and Dong Jing and Liu Ying and Haihong Zong and Liu Hua and Guenther Boden and Li Ling",
year = "2010",
month = "10",
doi = "10.231/JIM.0b013e3181ec5db2",
language = "English (US)",
volume = "58",
pages = "883--886",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension

AU - Mengliu, Yang

AU - Gangyi, Yang

AU - Jing, Dong

AU - Ying, Liu

AU - Zong, Haihong

AU - Hua, Liu

AU - Boden, Guenther

AU - Ling, Li

PY - 2010/10

Y1 - 2010/10

N2 - Chemerin is a recently discovered metabolic regulator hormone. The pathophysiologic role of this hormone in humans remains unknown. In this study, we have compared plasma chemerin levels in patients with type 2 diabetes mellitus with or without hypertension and in control subjects. We also assessed the association of plasma chemerin with body composition and metabolic parameters in these subjects. Plasma chemerin levels were found to be markedly increased in patients with type 2 diabetes mellitus with hypertension as compared with patients with type 2 diabetes mellitus and normal controls (P < 0.01). Multiple regression analysis showed that waist circumference, diastolic blood pressure, 2-hour plasma insulin after glucose overload, and HbA1c were independently related factors influencing plasma chemerin levels. The present work indicates the potential link of chemerin with the pathogenesis of insulin resistance, obesity, and metabolic syndrome.

AB - Chemerin is a recently discovered metabolic regulator hormone. The pathophysiologic role of this hormone in humans remains unknown. In this study, we have compared plasma chemerin levels in patients with type 2 diabetes mellitus with or without hypertension and in control subjects. We also assessed the association of plasma chemerin with body composition and metabolic parameters in these subjects. Plasma chemerin levels were found to be markedly increased in patients with type 2 diabetes mellitus with hypertension as compared with patients with type 2 diabetes mellitus and normal controls (P < 0.01). Multiple regression analysis showed that waist circumference, diastolic blood pressure, 2-hour plasma insulin after glucose overload, and HbA1c were independently related factors influencing plasma chemerin levels. The present work indicates the potential link of chemerin with the pathogenesis of insulin resistance, obesity, and metabolic syndrome.

KW - Body composition

KW - Chemerin

KW - Hypertension

KW - Metabolic parameters

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=78651503539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651503539&partnerID=8YFLogxK

U2 - 10.231/JIM.0b013e3181ec5db2

DO - 10.231/JIM.0b013e3181ec5db2

M3 - Article

VL - 58

SP - 883

EP - 886

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 7

ER -